These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
3. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen]. Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205 [TBL] [Abstract][Full Text] [Related]
5. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Swerdlow AJ; Jones ME; J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574 [TBL] [Abstract][Full Text] [Related]
8. [Estrogens and progestins in hormone replacement therapy in menopause]. La Vecchia C Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854 [TBL] [Abstract][Full Text] [Related]
9. [Tamoxifen and endometrial cancer]. Salamanca-Gómez F Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554 [No Abstract] [Full Text] [Related]
10. Gynaecology. Hormonal interventions and cancer risk. Neven P; De Muylder X Lancet; 1995 Dec 23-30; 346 Suppl():s8. PubMed ID: 9454051 [No Abstract] [Full Text] [Related]
11. Postmenopausal HRT--a role for a safe antioestrogen. Williams GM Int J Clin Pract; 1998; 52(1):5. PubMed ID: 9536558 [No Abstract] [Full Text] [Related]
13. [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case]. Menada MV; Corticelli A; Giannesi A; Nicoletti L; Podesta M; Rissone R; Fulcheri E Minerva Ginecol; 2000 Dec; 52(12):521-6. PubMed ID: 11310150 [TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinoma can develop in patients on tamoxifen therapy. Omar SZ; Sivanesaratnam V Med J Malaysia; 1999 Jun; 54(2):280-2. PubMed ID: 10972045 [No Abstract] [Full Text] [Related]
15. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report. Sinawat S; Chiyabutra T; Kleabkaew P J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study. Dew JE; Wren BG; Eden JA Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110 [TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature. Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149 [TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinoma and tamoxifen: clearing up a controversy. Andersson M; Storm HH; Mouridsen HT Clin Cancer Res; 1996 Jan; 2(1):223-4. PubMed ID: 9816110 [No Abstract] [Full Text] [Related]
19. Hormone replacement therapy, breast and endometrial cancer. La Vecchia C Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283 [No Abstract] [Full Text] [Related]
20. Overview of studies on endometrial cancer and other types of cancer in humans: perspectives of an epidemiologist. MacMahon B Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-122-S1-39. PubMed ID: 9045310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]